Thematische Bibliographien / Polmacoxib

Inhaltsverzeichnis

  1. Zeitschriftenartikel

Auswahl der wissenschaftlichen Literatur zum Thema „Polmacoxib“

Autor: Grafiati
Veröffentlicht am 7. Juni 2025
Zuletzt aktualisiert am 2. August 2025

Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an

Wählen Sie eine Art der Quelle aus:

Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Polmacoxib" bekannt.

Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.

Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.

Zeitschriftenartikel zum Thema "Polmacoxib"

1

S., Manjula, and Krishna Kumar M. "Expert perspectives on polmacoxib monotherapy in the management of osteoarthritis in Indian settings." International Journal of Research in Orthopaedics 11, no. 1 (2024): 118–23. https://doi.org/10.18203/issn.2455-4510.intjresorthop20243896.

Der volle Inhalt der Quelle
Annotation:
Background: Although there were several clinical studies available, there was a dearth of studies among clinicians in actual practice. So, the present survey-based study aimed to gather expert perspectives on the clinical use of polmacoxib monotherapy for the management of osteoarthritis (OA) in routine Indian settings. Methods: This cross-sectional study employed a 19-item questionnaire to gather expert opinions on managing OA and covered topics such as prescription practices, clinical observations, preferences and experiences with polmacoxib for routine OA management. Descriptive statistics
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Krishna Kar and Bhavisha Patel. "“A Comprehensive Review on Selective Dual Inhibitor NSAID - Polmacoxib”." Journal of Advanced Zoology 45, no. 1 (2024): 885–89. http://dx.doi.org/10.17762/jaz.v45i1.3431.

Der volle Inhalt der Quelle
Annotation:
The review article provides extensive overview on the promising pharmaceutical compound, polmacoxib also known as CG100649, explaining its pharmacological properties, chemical and physical properties, clinical studies and analytical methods. Polmacoxib is a novel nonsteroidal anti-inflammatory drug (NSAID) that has shown significant interest in recent years for its potential therapeutic benefits in Osteoarthritis treatment and distinct analytical characteristics. The chemical and pharmacological section in this review depicts the choice of solvents to be used through its solubility profile and
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Rashmi, Chandra* Ravi Kumar Shoebul Haque D. K. Katiyar Arpit Singh. "COX-2 Selectivity and Beyond: Exploring Polmacoxib Role in Knee Osteoarthritis Treatment." International Journal of Pharmaceutical Sciences 3, no. 4 (2025): 2157–65. https://doi.org/10.5281/zenodo.15235364.

Der volle Inhalt der Quelle
Annotation:
Knee osteoarthritis (KOA), a prevalent degenerative joint disease, significantly impacts global health, particularly among the elderly and individuals engaged in physically demanding jobs. Conventional treatments ranging from lifestyle modifications to NSAIDs and surgical interventions often provide limited long-term relief and may carry substantial risks, especially cardiovascular and gastrointestinal side effects. Polmacoxib, a novel NSAID and selective COX-2 inhibitor, offers a promising alternative due to its dual mechanism of action. It inhibits both COX-2 and carbonic anhydrase (CA), ena
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Ahmad Farooqui, Dr Nasiruddin, Ms Priyanka Ms. Priyanka, Mr Mohd Salman Mr. Mohd Salman, and Mr Praveen Kumar. "Formulation and evaluation of mouth dissolving film of polmacoxib." International Journal of Pharmaceutical Research and Applications 10, no. 3 (2025): 1739–49. https://doi.org/10.35629/4494-100317391749.

Der volle Inhalt der Quelle
Annotation:
The current work concentrates on the analytical quantification and formulation development of Polmacoxib, a selective COX-2 inhibitor, by establishing a UV spectrophotometric calibration curve and characterizing mouth-dissolving films (MDFs). Using UV spectrophotometry, a standard calibration curve of Polmacoxib was created. It showed great linearity in the concentration range of 2–12 µg/mL, with a strong link between absorbance and concentration, which proved that it could be used for quantitative analysis. After the analytical validation, several mouth-dissolving film formulations (F1–F6) of
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Chaudhary, Anjali, Meenakshi Dhaiya, Shaily Tyagi, and Swati Mittal. "Method Development and Validation of Polmacoxib in Capsule Dosage Form by RP-HPLC." Journal of Drug Delivery and Therapeutics 11, no. 4-S (2021): 59–63. http://dx.doi.org/10.22270/jddt.v11i4-s.4984.

Der volle Inhalt der Quelle
Annotation:
A simple and sensitive RP-HPLC method developed for estimation of Polmacoxib in bulk by using a high performance liquid chromatography with PDA detector using Phenomenex luna C18 column (250mmx4.6mm), 5 µm; mobile phase comprises of Water : ACN as (1:1) at the flow rate 1.0 ml/min and the wavelength of detection 238 nm and eluted at 8.12 minutes. The proposed method is validated for specificity, Linearity, Precision, accuracy, ruggedness, and Robustness. All the parameters were found within the acceptable limits. RP-HPLC method was a simple, reliable economic and acceptable and it confirmed th
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Rathore, Rohit Singh, and Bhavisha Patel. "FORMULATION AND EVALUATION OF HERBAL TABLET CONTAINING POLMACOXIB FOR THE TREATMENT OF MONKEYPOX VIRUS." Cuestiones de Fisioterapia 54, no. 2 (2025): 3590–602. https://doi.org/10.48047/bmhkzj46.

Der volle Inhalt der Quelle
Annotation:
This study aims for formulation and evaluation of herbal drug formulation consist Sarracenia purpurea, Kanchnar guggulu, Lemon balm and incorporating Polmacoxib an anti-inflammatory drug suppresses the production of pro-inflammatory substances (Prostaglandins) by inhibiting certain enzymes involved in inflammation which was found to be novel and versatile to enhance treatment outcome of monkey pox virus.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Cho, Yong-Soon, Kyun-Seop Bae, Seung Chan Choi, Joong Myung Cho, and Hyeong-Seok Lim. "Population Pharmacokinetic and Pharmacodynamic Analysis of Polmacoxib in Healthy Volunteers and Patients With Osteoarthritis." Clinical Therapeutics 44, no. 1 (2022): 67–80. http://dx.doi.org/10.1016/j.clinthera.2021.11.008.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Kim, Hyun Tae, Hyunju Cha, and Kwang Yeon Hwang. "Structural insight into the inhibition of carbonic anhydrase by the COX-2-selective inhibitor polmacoxib (CG100649)." Biochemical and Biophysical Research Communications 478, no. 1 (2016): 1–6. http://dx.doi.org/10.1016/j.bbrc.2016.07.114.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

Prabhoo, Dr Ram, and Dr Nirbhay Shrivastava. "The role of polmacoxib as a tissue-specific cox-2 inhibitor in the management of osteoarthritis: A comprehensive review." International Journal of Orthopaedics Sciences 10, no. 3 (2024): 84–91. http://dx.doi.org/10.22271/ortho.2024.v10.i3b.3582.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Lee, Myungchul, Juhyung Yoo, Jin Goo Kim, et al. "A Randomized, Multicenter, Phase III Trial to Evaluate the Efficacy and Safety of Polmacoxib Compared with Celecoxib and Placebo for Patients with Osteoarthritis." Clinics in Orthopedic Surgery 9, no. 4 (2017): 439. http://dx.doi.org/10.4055/cios.2017.9.4.439.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
Mehr Quellen
Die Auswahlen zum Thema "Polmacoxib" für konkrete Quellenarten können Sie auch interessieren:
Zeitschriftenartikel
Wir bieten Rabatte auf alle Premium-Pläne für Autoren, deren Werke in thematische Literatursammlungen aufgenommen wurden. Kontaktieren Sie uns, um einen einzigartigen Promo-Code zu erhalten!

Zur Bibliographie